Retina

Healio’s articles from the American Society of Retina Specialists meeting have covered long-term improvements with Luxturna and macular hole closure rates with different pars plana vitrectomy techniques.

In this Healio Video Perspective from the ASRS annual meeting, Dilraj Grewal, MD, FASRS, discusses eyes that developed macular neovascularization in the GATHER trials.

In this Healio Video Perspective from the ASRS meeting, Carl C. Awh, MD, FASRS, of Tennessee Retina discusses the phase 3 Pagoda trial investigating the port delivery system with ranibizumab for diabetic macular edema.

In this Healio Video Perspective from the ASRS meeting, Durga Borkar, MD, of Duke University Eye Center presents data from a phase 1b study investigating ONL1204, a Fas inhibitor, for geographic atrophy.

In this Healio Video Perspective from the ASRS meeting, Margaret Chang, MD, MS, of Retinal Consultants Medical Group presents 2-year results for the port delivery system with ranibizumab.

In this Healio Video Perspective from the ASRS meeting, Arshad M. Khanani, MD, MA, FASRS, discusses the just-released 4-year efficacy and safety outcomes of faricimab in diabetic macular edema.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, discusses efficacy and safety data for the port delivery system ahead of its reintroduction.

PARK CITY, Utah — Stage one of the phase 3 DIAMOND trial of OCS-01, a high-concentration dexamethasone eye drop for diabetic macular edema, showed promising safety and efficacy outcomes. Stage two of the trial is underway.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Doug Faunce, PhD, reviews AbbVie’s ongoing efforts in the eye care field.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Charles Semba, MD, chief medical officer of Eluminex Biosciences, discusses a trispecific antibody for refractory diabetic macular edema.